drugset / Trial / NCT03218501
A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy, safety and dose response of SK-1405 for the treatment of subjects with uremic pruritus receiving hemodialysis, during 2 weeks of treatment.
Timeline
- Start
- 2017-08-28
- Primary completion
- 2018-05-25
- Completion
- 2018-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SK-1405 | Unknown | — | Oral |
Indications
No indication recorded.